Revenue Recognition (Tables)

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Schedule of Revenue Disaggregated by Type of Customer

The following table summarizes the Company’s disaggregated revenue by payor category:

	Year ended December 31,
	2024						2023
	GeneDx		Other1		Total		GeneDx		Other1		Total
Diagnostic test revenue:
Patients with third-party insurance	$	231,542	$	3,157	$	234,699	$	126,265	$	8,226	$	134,491
Institutional customers	65,115		—		65,115		59,497		—		59,497
Self-pay patients	2,343		—		2,343		1,702		(36)		1,666
Total diagnostic test revenue	299,000		3,157		302,157		187,464		8,190		195,654
Other revenue	3,293		—		3,293		6,912		—		6,912
Total	$	302,293	$	3,157	$	305,450	$	194,376	$	8,190	$	202,566

__________________

(1)Other represents revenues associated with the Legacy Sema4 diagnostic testing business.